Journal Watch · Cell Reports · 2026

DNA-PKcs controls the cytotoxic T cell response to cancer and transplant allograft through regulating LAT-dependent signaling.

These data highlight DNA-PKcs as a pivotal protein in T cell function.

Rainwater RR, Azevedo-Pouly AC, Waldrip ZJ et al.Cell Reports3 min readPharma relevance 30/100

DOI: 10.1016/j.celrep.2025.116796PMID: 41505255Study type: preclinical (animal / model) study

TL;DR

These data highlight DNA-PKcs as a pivotal protein in T cell function.

Key findings

  • We identified two LAT serines phosphorylated by DNA-PKcs, S224 and S241, that impact LAT tyrosine phosphorylation, protein binding, and cytokine production.
  • Using our mouse model designed to delete DNA-PKcs expression in mature CD4<sup>+</sup> or CD8<sup>+</sup> T cells, we show that loss of DNA-PKcs results in T cells that are unable to control tumor growth or induce allogeneic graft rejection.
  • These data highlight DNA-PKcs as a pivotal protein in T cell function.

What they did

Here, we show that upon T cell activation, DNA-dependent protein kinase catalytic subunit (DNA-PKcs) interacts with LAT and localizes to the IS. Inhibition of DNA-PKcs diminishes LAT localization at the IS.

Full abstract (original)

Background: Formation of the immune synapse (IS) following T cell antigen recognition includes recruitment of the linker for activation of T cells (LAT). Once at the IS, LAT tyrosines are phosphorylated, allowing it to serve as a scaffold for the formation of the "signalosome," a multiprotein complex that drives T cell receptor signaling.

What they did: Here, we show that upon T cell activation, DNA-dependent protein kinase catalytic subunit (DNA-PKcs) interacts with LAT and localizes to the IS. Inhibition of DNA-PKcs diminishes LAT localization at the IS.

Results & conclusions: We identified two LAT serines phosphorylated by DNA-PKcs, S224 and S241, that impact LAT tyrosine phosphorylation, protein binding, and cytokine production. Using our mouse model designed to delete DNA-PKcs expression in mature CD4<sup>+</sup> or CD8<sup>+</sup> T cells, we show that loss of DNA-PKcs results in T cells that are unable to control tumor growth or induce allogeneic graft rejection. These data highlight DNA-PKcs as a pivotal protein in T cell function.

Abstract © the authors / Cell Reports (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1016/j.celrep.2025.116796 · PubMed 41505255.

Why it matters for pharma & biotech

  • Relevant to Biology & Life Sciences teams tracking Cell Reports for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Cell Reports study find?

These data highlight DNA-PKcs as a pivotal protein in T cell function.

What type of study is this?

It is a preclinical (animal / model) study, published in Cell Reports in 2026. Here, we show that upon T cell activation, DNA-dependent protein kinase catalytic subunit (DNA-PKcs) interacts with LAT and localizes to the IS.

Where can I read the original paper?

The original is at the publisher via DOI 10.1016/j.celrep.2025.116796. PubMed ID: 41505255. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Rainwater RR, Azevedo-Pouly AC, Waldrip ZJ et al.. DNA-PKcs controls the cytotoxic T cell response to cancer and transplant allograft through regulating LAT-dependent signaling.. Cell Reports (2026). DOI: 10.1016/j.celrep.2025.116796.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/dna-pkcs-controls-the-cytotoxic-t-cell-response-to-cancer-and-transplant-116796/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides